- Home
- IPA
as 03-28-2025 4:00pm EST
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
| Founded: | 1983 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 19.3M | IPO Year: | 2017 |
| Target Price: | $5.00 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.13 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.27 - $1.59 | Next Earning Date: | 03-28-2025 |
| Revenue: | $16,581,105 | Revenue Growth: | 1.35% |
| Revenue Growth (this year): | 1.88% | Revenue Growth (next year): | 9.90% |
Latest ImmunoPrecise Antibodies Ltd. News
IPA Breaking Stock News: Dive into IPA Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024)
Business Wire
3 days ago
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025
Simply Wall St.
18 days ago
Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock
Business Wire
18 days ago
ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
Business Wire
19 days ago
IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025
Business Wire
a month ago
IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025
Business Wire
a month ago
IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy
Business Wire
a month ago
ImmunoPrecise Antibodies Announces Key Leadership Changes
Compare IPA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IPA ImmunoPrecise Antibodies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.